STERIS’ (TSE:STE – Free Report) – Stock analysts at Atb Cap Markets upped their FY2025 earnings estimates for shares of STERIS’ in a research report issued to clients and investors on Wednesday, March 12th. Atb Cap Markets analyst W. Syed now forecasts that the company will earn $0.59 per share for the year, up from their previous estimate of $0.43. Atb Cap Markets has a “Strong-Buy” rating on the stock. Atb Cap Markets also issued estimates for STERIS’’s Q4 2025 earnings at ($0.11) EPS and Q4 2026 earnings at ($0.09) EPS.
Separately, Cormark raised STERIS’ to a “moderate buy” rating in a research note on Monday, January 6th.
STERIS’ Stock Performance
STERIS’ Company Profile
STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.
Featured Stories
- Five stocks we like better than STERIS’
- The 3 Best Fintech Stocks to Buy Now
- How to Build the Ultimate Everything ETF Portfolio
- Golden Cross Stocks: Pattern, Examples and Charts
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- 3 Stocks With High ROE and Market-Beating Growth Potential
Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.
